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Abstract: The aim of the study was to evaluate the anti-obesity effect of butenolic fraction of 
Ixora pavettain high fat diet induced obesity in wistar rats. Female rats were fed with high fat 
diet for 8 weeks. Butenolic fraction of Ixora pavetta (BIP) was administered at a dose of 250 
mg/kg, p.o. and 500 mg/kg for last 3 weeks while high fat diet offering.  Atorvastatin 30 mg/kg 
P.O. was used as a standard.  The effect of BIP on following parameters was recorded - body 
weight, feed consumption and various biochemical parameters like serum glucose, serum lipid 
profile eg.total cholesterol (TC) and triglyceride (TG), HDL-C, LDL-C, VLDL and atherogenic 
index. Other biochemical parameters like SGOT, SGPT and total protein were estimated. Finally 
effect on vital organs like liver, heart and kidney as well as epididymal fat pad was also 
recorded.There was a significant reduction in body weight and other increased biochemical 
parameters like serum glucose levels, TG, TC, LDL-C, VLDL, SGOT and SGPT. Decreased HDL-C 
level in HFD fed animals were significantly improved due to treatment of BIP. Atheroginic index 
as well as epididymal fat pad weight was found to be reduced due to BIP treatment. The 
results by test and standard drug were comparable. The result strongly indicates butenolic 
fraction of Ixora pavettaposses anti-obesity action in high fat diet induced obesity in wistar 
rat’s model. 
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INTRODUCTION 
Obesity is a chronic disease of increasing prevalence in most countries, which leads to 
substantial increase in morbidity, and mortality in association with insulin resistance, diabetes, 
hyperlipidaemia, hypertension, and other cardiovascular diseases1. Among the multiple factors 
contributing to its etiology, the sedentary life styles, white collar jobs, lack of exercise, psycho-
logical factors, and the consumption of energy rich diets are the major ones2. In Brief, obesity is 
an abnormal excessive growth of adipose tissue, results from the combined effects of excess 
energy intake and reduced energy expenditure3. 
Although a multitude of pharmaceutical agents are available for the treatment of obesity, the 
long-term persistence rate with medications is poor probably due to adverse effects, modest 
efficacy and expense. However, adverse effects of these drugs are not negligible, and must be 
taken into consideration when it is time to prescribe one of these anti-obesity drugs4,5. 
While extensive research has been conducted on the development of anti-obesity drugs, the 
phytoconstituents like flavonoids, saponin, alkaloids derived from plant sources, including 
caffeine in oolong tea6, saponin in the roots of broad bellflower7 and capsiate in sweet pepper8, 
for preventing and ameliorating obesity have been investigated. 
The plant, Ixora pavetta Andr is reported for presence of various phytochemicals like essential 
oil, flavanoids, saponins, resins, phytosterols, alkaloids, tannins. Due to presence of these 
phytochemicals, various parts of plants like flowers, root and leaves are claimed to have 
medicinal benefits in various disorders like  such as dysentery, leucorrhoea, dysmenorrhea, 
haemoptysis  bitter tonic, aperients, purgative, urinary disorders and is frequently prescribed in 
visceral obstructions9, 10. 
However, effect of Ixora pavetta or its phytoconstituents have not reported for anti-obesity 
effect. In the present study, the anti-obesity effects of Ixora pavetta was investigated in rats fed 
with High Fat (HF) diet by measuring changes in body weight, food consumption, serum 
biochemicalprofile,changes in  epididymal fat pad weights 
MATERIALS AND METHODS  
Collection of Plant material 
Fresh leaves of Ixora Pavetta was obtained from local area of Kadapa & authentified by 
Botanist; S.V University, Tirupathi, (A.P). The specimen voucher of same is kept in department 
of pharmacology; PRRM College of Pharmacy; Kadapa. 
Extraction and fractionation of Plant material 
The collected plant material ofIxora Pavetta was washed thoroughly in water, and air dried for 
two weeks. The 500 gm of air dried and coarsely powdered material of plants were extracted 
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with 95% of ethanol by cold maceration method for 72 hrs. Then the extract was filtered with 
muslin cloth and filtrate was evaporated under reduced pressure and vacuum dried. The 
yielded a greenish residue was 20- 25% W/W extract with reference to dry starting material. 
Further this alcoholic extract was fractioned with non polar solvents to polar solvents system 
(Pet ether – Chloroform - Ethyl acetate – n Butenol) and all fractions were tested for 
preliminary phytochemical tests. Butenolic fraction of the plant showed presence of maximum 
phytochemicals and hence this fraction is labeled as Butenolic Fraction of Ixora Pavetta (BIP) 
Experimental Animals 
Healthy adult female albino rats were procured from Raghavendra enterprises, Bangalore 
weighing between 100-150 g was used. They were housed under standard laboratory 
conditions and food and water were provided ad libitum. The temperature was kept at 22 ± 2º 
c. The animals were maintained under a 12 h light / 12 h darkness cycle. All animal procedures 
were approved by the Institutional Animal Ethical Committee of P. Rami Reddy Memorial 
college of pharmacy, Kadapa(Ref No: 1423/PO/a/11/CPCSEA/001). 
Chemicals: 
Most of Ingredients for High fat diet obtained from local market Kadapa. Atorvastatin and all 
other chemicals were procured from SD fine chemicals Ltd. India andwere of analytical grade. 
Composition of High fat diet and Induction of obesity: 
The composition of high fat diet contains 23% whole wheat, 23% yellow corn, 11% barley, 17% 
milk powder, 1% bone meal, 1 % calcium chloride, 1% sodium chloride, 11% coconut oil, 11% 
butter and one multivitamin capsule. The diet was prepared daily morning freshly and offered 
in form of ball to animals11. The rats were rendered obese by a HF diet, while the control rats 
had access to a normal (N) diet for the total period of 8 weeks. After 5 weeks of HF diet, the 
rats received daily treatment with test and standard drugs for another 3 weeks1.  
Experimental design 
The animals offered with High fat diet (HFD) for 5 weeks were divided into four groups (n=6). All 
groups were treated with test and standard drugs for further 3 weeks as fallows.  Normal 
control group offered with normal diet was maintained separately and received vehicle for 
treatment period.   
Butenolic Fraction of Ixora pavetta (BIP)and thestandard drug Atorvastatin were freshly 
suspended in 1% CMC daily and administered to animals by oral feeding needle immediately.  
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SN Group Treatment schedule (3 weeks): 
I Normal Normal feed + 1 % CMC (p.o.) 
II Control High fat diet + 1 % CMC (p.o) 
III Standard High fat diet + Atorvastatin (30 mg/kg ,p.o) 
IV Low dose 250 
mg/kg 
High fat diet + BIP (250 mg/kg, p.o.) 
V High dose 
500mg/kg 
High fat diet + BIP (500 mg/kg, p.o.) 
 
Measurements and sample collection 
Body weights and food intake were recorded twice a week throughout experimental period. At 
the end of experiment, the blood samples were collected from the retro orbital venous plexus 
of rats without any coagulant for the separation of serum. After collecting the blood into micro 
centrifuge tubes it is kept aside for 30 min at room temperature and then serum was separated 
by centrifugation at 2000 rpm for 15 min and stored at -80º C until analyzed for various 
biochemical parameters.  
After blood collection, animals were sacrificed by deep anesthesia and vital organs like liver, 
kidney, heart as well as epididymal fat pads were isolated and weighted immediately. 
Estimation of Biochemical Parameter: 
Various biochemical parameter like serum glucose, total cholesterol (TC) , HDL, Triglycerides 
(TG), SGOT, SGPT and total protein were estimated by using Erba kit and semi auto analyzer 
(Maxlyzer, Avecon model no: NB-201). Other parameters like LDL, VLDL and atherogenic index 
were calculated by using equitation-  
 VLDL= TG/5 
 LDL = {TC – (HDL + VLDL)} 
 Atherogenic index  =  LDL + VLDL 
                                                    HDL 
Statistical analysis 
All the data was expressed as Mean ± S.E.M. Statistical significance between more than two  
groups was tested using one way ANOVA followed by the Dunnet’s test using computer based  
fitting program (Prism graph pad.). Statistical significance was taken as P< 0.01.   
Research Article       CODEN: IJPRNK          IMPACT FACTOR: 4.278          ISSN: 2277-8713                                                       
Kanhere RS, IJPRBS, 2014; Volume 3(4): 594-605                                                             IJPRBS 
 
Available Online at www.ijprbs.com 
598 
RESULTS 
Body weight and Food consumption 
The body weight of each group was recorded twice a week throughout the study period. The 
results obtained where shown as Mean ±SEMin Fig No 1. Animals Offered with high fat deit 
showed gradual body weight gain with time as compaired to animals maintainted on normal 
deit.  
After 5 week offering of High fat deit (HFD), Animal treated with standered and test group for 
next 3 weeks showed significant reduction of body weight gain. Butenol fraction of Ixora 
pavetta (BIP) showed dose dependant reduction in body weight from Day 48 (p<0.01) to Day 57 
(p<0.0001) when compaired to HFD control group. Animals treated with standered drug i.e. 
Atorvastatin 30 mg/ kg P.O also showed statistically significant (p<0.0001) reduction in body 
weight gain 
 
Figure 1:- Effect of BIP on body weight gain 
Day wise body weight for experimental group.  Values are represented as Mean ± SEM. 
Statistical analysis performed using one way ANOVA followed by dunnett’s test for each 
individual day. a- P<0.0001vs Normal Diet group; b- P<0.0001 vs HFD control group; c- P<0.01 vs 
HFD control group (should be written as caption for Fig 1) (Start New paragraph) Feed 
consumption was calculated from feed offered and feed left to next day (including weastage of 
feed in cage). Feed consumption of all the groups was recored every day throughout 
experimental period. The results were expressed as feed consumed per animal per day in gram. 
Feed consumption pattern for all the treated and control group was found simillar as shown in 
Fig No 2. 
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Figure 2:- Feed consumption 
Feed consumption data for each group. Values are represented as feed consumed per animal 
per day in gram. 
Serum Parameters 
Effect on Biochemical Parameters 
Serum biochemical parameters were estimated by using Erba kit. The results obtained where 
shown as Mean± SEM in Fig No 3, 4 and Table 1. The animals fed with high fat diet showed 
significant increase (P<0.0001) in glucose and lipid parameters like Cholesterol (TC), 
Triglycerides (TG), VLDL and LDL as well as other biochemical parameters like SGOT and SGPT 
level when compared to the normal group animals. The treatment with BIP showed a dose 
dependent decrease in all elevated biochemical parameter level in high fat feed rats. BIP 250 
mg/kg b.w. p.o and 500 mg/kg b.w. p.o. showed significant decrease (P<0.001, P<0.0001 
respectively) in glucose and lipid parameter level when compared with HFD control group. In 
case of SGOT and SGPT, the high dose of BIP i.e. 500 mg/kg treatment was able to produce 
significant reduction (P<0.001), However treatment with low dose of BIP (250mg/kg) was 
unable to produce any significant achievement. Similar kind of results was obtained in case of 
HDL-C. HDL-C level of high fat diet control animals were found be significantly decreased 
(P<0.0001) as compared to the normal group animals.BIP 500 mg/kg treatment was able to 
normalized HDL level and showed significant increased level (P<0.001) when compared with 
HFD control group, However BIP 250 mg/kg treatment was unable to produce significant 
improvement in HDL levels. Standard drug treatment i.e. Atorvastatin showed significant result 
in all parameters which were comparable to results shown by high dose treatment of BIP  
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Figure 3:- Effect on serum glucose level 
Values are represented as Mean ± SEM .Statistical analysis performed using one way ANOVA 
followed by dunnett’s test for each individual day. a- P<0.0001vs Normal Diet group; b- 
P<0.0001 vs HFD control group; c- P<0.001 vs HFD control group. 
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Figure 4:- Effect on serum Lipid Profile 
Values are represented as Mean ± SEM .Statistical analysis performed using one way ANOVA 
followed by dunnett’s test for each individual day. a- P<0.0001vs Normal Diet group; b- 
P<0.0001 vs HFD control group; c- P<0.001 vs. HFD control group. 
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Table 1:- Effect on Serum SGOT, SGPT and Total Protein 
Effect on other 
biochemical parameters 
Groups Values (Mean ± SEM) 
Normal 
Diet 
HFD 
Control 
HFD + 
Atorvastatin 
HFD + BIP 
250 mpk 
HFD + BIP 
500 mpk 
SGOT (mg/dl) 81.0 ± 
6.09 
144.13 ± 
5.54a 
92.83 ± 
5.02b 
122.33 ± 
14.05 
101.50 ± 
9.24c 
SGPT (mg/dl) 18.83 ± 
1.86 
42.96 ± 
5.23a 
20.83 ± 2.4b 32.0 ± 2.43 24.0 ± 2.32 c 
Total Protein (g/dl) 5.9 ± 
0.42 
6.66 ± 
0.39 
6.33 ± 0.28 6.5 ± 0.40 6.66 ± 0.39 
Values are represented as Mean ± SEM .Statistical analysis performed using one way ANOVA 
followed by dunnett’s test for each individual day. a- P<0.0001vs Normal Diet group; b- 
P<0.0001 vs HFD control group; c- P<0.001 vs. HFD control group 
Atherogenic Index 
Atherogenic index (AI) was calculated for each animal and the results obtained where shown as 
Mean ± SEM inFigure no 5. Mean AI for animals fed with normal diet was found to be 1.25 
± 0.27. Animals offered with High fat diet showed significant increase (P<0.0001) in AI (6.48 
± 0.97). Mean AI for Atorvastatin 30 mg/kg, p.o., BIP 250 mg/kg p.o and  500 mg/kg p.o. 
treatment groups were found to be 1.64 ± 0.18, 3.0 ± 0.55 and 1.70 ± 0.99 respectively. The 
reduction of AI by all treatments were significant (P<0.0001) as compared to HFD control group. 
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Figure 5:- Atherogenic Index 
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Values are represented as Mean ± SEM .Statistical analysis performed using one way ANOVA 
followed by dunnett’s test for each individual day. a- P<0.0001vs Normal Diet group; b- 
P<0.0001 vs HFD control group 
Organ Weight and Epididymal Fat pad weight 
End of the experiment, all animals were humanely sacrificed and vital organs like Liver, Kidney 
and Heart as well as epididymal fat pads were isolated and weighted immediately. The relative 
organ weights (gm/ Kg b.w) for each animal were calculated as per following formulae and 
results were represented in Mean ± SEM in Table 2.  
Relative Organ weight       = 
(g/kg b. wt)  
(Absolute organ weight in grams/body weight in grams 
of final day) X 1000        
 
The animals fed with high fat diet showed significant increase in Liver (P<0.0001), Heart 
(P<0.001) and Epididymal fat pad (P<0.0001) weight (relative) when compared to the normal 
group animals. However Kidney weights were found unaltered due to High fat diet.  Standard 
drug treatment i.e. Atorvastatin showed significant decrease in Liver weight (P<0.01) and 
Epididymal fat pad weight (P<0.0001) when compared to control group. The treatment with BIP 
showed a dose dependent decrease in increased eipididymal fat pad weights in high fat feed 
rats. BIP 250 mg/kg b.w. p.o and 500 mg/kg b.w. p.o. showed significant decrease (P<0.001) in 
eipididymal fat pad weights when compared with HFD control group. Moreover high dose of 
BIP was found to effective in decreasing increased liver weight.  
Table 2:- Effect on organ weights and fat pad weight 
Groups 
 Normal 
diet 
HFD 
control 
HFD + 
Atorvastati
n 
HFD + BIP 
250 mpk 
HFD + BIP 
500 mpk 
Relative Liver 
Weight (gm/kg b.wt.) 
41.39 ± 
4.19 
53.72 ± 
2.34a 
40.26 ± 
3.22c 
52.52 ± 
1.58 
41.20 ± 
4.16c 
Relative Kidney Weight (gm/kg 
b.wt.) 
9.40 ± 
0.55 
9.51 ± 
0.29 
9.54 ± 0.25 9.73 ± 0.38 9.92 ± 0.30 
Relative Heart 
Weight (gm/kg b.wt.) 
3.63 ± 
0.27 
5.60 ± 
0.48b 
5.66 ± 0.37 5.16 ± 0.30 5.47 ± 0.47 
Relative Epididymal  Fat Pad 
Weight (gm/kg b.wt.) 
10.20 ± 
0.22 
16.50 ± 
0.99 a 
11.51 ± 
1.05e 
12.16 ± 
0.62d 
12.05 ± 
0.82d 
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Values are calculated as relative weight and represented  as Mean ± SEM .Statistical analysis 
performed using one way ANOVA followed by dunnett’s test for each individual day. a- 
P<0.0001vs Normal Diet group; b- P<0.001 vs Normal Diet group; c- P<0.01 vs. HFD control 
group; d- P<0.001 vs. HFD control group ; e- P<0.0001 vs. HFD control group. 
DISCUSSION 
The present study demonstrates the beneficial effect of butenolic fraction of Ixora pavetta in 
high fat diet induced obesity model. The body weights, feed consumption, serum biochemical 
parameters and vital organ weight as well as epididymal fat pad weight were investigated in 
rats feed with normal diet and High fat diet. Effects of standard and test drugs on all this 
parameters were explored.  The outcome of the study clearly indicates the offering of High fat 
diet for period of 8 week to the animals resulted into drastic body weight gain as well as 
alteration of various biochemical parameters. These caused alterations were normalized by 3 
week treatment of butenolic fraction of Ixora pavetta at 250 mg/kg p.o. and 500 mg/kg p.o. 
treatment. These doses were selected from earlier published literature where Ioxa pavetta was 
found safe even at 4000mg/kg 12. The results were compared to standard treatment with 
hypolipedemic drug Atorvastatin 30 mg/kg p.o. However cumulative food intake of all groups 
throughout experimental period was similar.  
It is well established that elevated cholesterol, Triglycerides and LDL-cholesterol levels in serum 
as well as a low level of HDL-C is associated with high risk of obesity and associated coronary 
artery disease 13,.  Reduction in Total cholesterol, LDL- cholesterol and increase in HDL-
concentration are significantly related to lipid-lowering therapy. 3 week treatment with BIP 
250mg/kg p.o. as well as 500 mg/kg p.o. to high fat diet offered animals resulted into reduction 
of total cholesterol, Triglycerides, LDL – Cholesterol as well as increase in HDL – cholesterol 
indicates its potential in lipid lowering therapy.  
Generally, it is difficult to detect the CVD risk factor based on individual lipoproteins (TC, LDL-C, 
HDL-C) and TG levels. Consequently, the Atherogenic index (TC to HDL-C ratio) was used for this 
purpose14.  Treatment of BIP at both doses to HFD feed rats resulted into reduction of 
atherogenic index  
The increase in epididymal fat pad weight, Liver weight and Heart weight in HFD fed animals 
suggested tissue deposition of the fats. Results obtained were in accordance with the changes 
noticed in body weight pattern. Parallel to increased Body weight reduction, all the treatments 
were found to be effective to reduce regional epididymal fat pad weight. 
CONCLUSION 
Thus the present study indicates that the butenolic fraction of Ixora pavetta posses anti-obesity 
effect. The presence of various phytochemicals like essential oil, flavanoids, saponins and 
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alkaloids in BIP may responsible for its effect.  Further studies to understand actual underlying 
mechanism as well as studies on isolation and structural determination of active principles are 
in progress. 
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